Cargando…

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment

Triple negative breast cancer (TNBC), which has poor prognosis, easily develops drug resistance and metastasizes. In general, those TNBC characteristics are related to a high activation of the epithelial-mesenchymal transition (EMT) pathway, which is inhibited by shikonin (SKN). Therefore, the syner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Wu, Shen, Zhehao, Wang, Menglan, Wang, Hongyi, Sun, Yuting, Tao, Xiaojun, Hou, Defu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055947/ https://www.ncbi.nlm.nih.gov/pubmed/36986473 http://dx.doi.org/10.3390/ph16030374

Ejemplares similares

Biodegradable Redox-Sensitive Star Polymer Nanomicelles for Enhancing Doxorubicin Delivery
por: Li, Meng, et al.
Publicado: (2019)

Synthesis and Characterization of Folic Acid-Functionalized DPLA-co-PEG Nanomicelles for the Targeted Delivery of Letrozole
por: Rostami, Neda, et al.
Publicado: (2023)

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
por: Zhang, Xinyi, et al.
Publicado: (2020)

Recent Advances in Nanomicelles Delivery Systems
por: Tawfik, Salah M., et al.
Publicado: (2020)

Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
por: Gu, Fenfen, et al.
Publicado: (2022)

Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu, Yue, et al.
Publicado: (2016)

Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy
por: Sohail, Muhammad, et al.
Publicado: (2022)

Characterization of folic acid‐functionalized PLA–PEG nanomicelle to deliver Letrozole: A nanoinformatics study
por: Rostami, Neda, et al.
Publicado: (2021)

Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014)

Nanomicelles: Types, properties and applications in drug delivery
por: Bose, Anamika, et al.
Publicado: (2021)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023)

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
por: Han, Ling-Na, et al.
Publicado: (2022)

Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy
por: Chen, Lili, et al.
Publicado: (2018)

Correction to “Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)

Self-Assembling Tacrolimus Nanomicelles for Retinal Drug Delivery
por: Gote, Vrinda, et al.
Publicado: (2020)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
por: Wu, Di, et al.
Publicado: (2019)

Folate-Functionalized DNA Origami for Targeted Delivery of Doxorubicin to Triple-Negative Breast Cancer
por: Pal, Suchetan, et al.
Publicado: (2021)

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
por: Zeng, Weiwei, et al.
Publicado: (2023)

Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles
por: Xia, Yu, et al.
Publicado: (2018)

Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
por: Wang, Anqi, et al.
Publicado: (2021)

Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation
por: Zhang, Yuchen, et al.
Publicado: (2015)

In vitro and in vivo evaluation of a novel mitomycin nanomicelle delivery system
por: Yang, Hongmei, et al.
Publicado: (2019)

Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness
por: Zhao, Weidong, et al.
Publicado: (2022)

Reduction-Sensitive Dual Functional Nanomicelles for Improved Delivery of Paclitaxel
por: Zhang, Xiaolan, et al.
Publicado: (2014)

Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles
por: Yuan, Xue, et al.
Publicado: (2017)

Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
por: Wang, He-Wen, et al.
Publicado: (2020)

Nanomicelle‐Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo
por: Weng, Yu‐Hua, et al.
Publicado: (2017)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells
por: Wen, Xianchun, et al.
Publicado: (2018)

Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib
por: Xv, Liuli, et al.
Publicado: (2020)

Aptamer-based self-assembled nanomicelle enables efficient and targeted drug delivery
por: Chen, Ganghui, et al.
Publicado: (2023)

Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
por: Hu, Yuzhu, et al.
Publicado: (2020)

Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance
por: Guo, Weihong, et al.
Publicado: (2018)

Treatment of colorectal cancer by anticancer and antibacterial effects of hemiprotonic phenanthroline-phenanthroline(+) with nanomicelle delivery
por: Zhang, Yingying, et al.
Publicado: (2023)

Transdermal Delivery of Glimepiride: A Novel Approach Using Nanomicelle-Embedded Microneedles
por: Pervez, Sadia, et al.
Publicado: (2023)

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
por: Gong, Chunai, et al.
Publicado: (2019)

Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer
por: Behl, Akanksha, et al.
Publicado: (2022)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
por: Bawaneh, Alaa, et al.
Publicado: (2022)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4u5josvcifp9d27vhtrf1e710q